To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NUF2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
199 supporting clones for gene NUF2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG718424 testis .a 1 to 782 1 to 784   tiling clone,   784/784
(100 %)
9 diff
(98.9 %id)
NM_031423.3   .a 4 to 1846 1 to 1843 exact RefSeq,   1843/1843
(100 %)
0 diff
(100 %id)
DB030496 testis .a 26 to 563 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
BF669372 brain, primitive neuroectoderm .a 27 to 730 1 to 701       701/767
(91 %)
29 diff
(96.3 %id)
AF326731   .a 35 to 1840 9 to 1814 S229L tiling clone, AAA   1806/1806
(100 %)
2 diff
(99.9 %id)
CN366169 embryonic stem cells, cell lines H1, H7, andH9 .a 42 to 417 1 to 376       376/376
(100 %)
3 diff
(99.3 %id)
DA754036   .a 45 to 605 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
CN366172 embryonic stem cells, cell lines H1, H7, andH9 .a 55 to 639 1 to 586       586/586
(100 %)
2 diff
(99.7 %id)
BE778104 eye, retinoblastoma .a 58 to 760 1 to 695       695/927
(74 %)
14 diff
(98.5 %id)
AA305229 colon .a 66 to 331 1 to 266       266/266
(100 %)
1 diff
(99.7 %id)
BF239554 bone marrow, from chronic myelogenous leukemia .a 70 to 583 1 to 510       510/759
(67 %)
14 diff
(98.2 %id)
BC008489 Bone marrow, chronic myelogenous leukemia .a 71 to 1838 1 to 1768 exact tiling clone, available from MGC, AAA   1768/1768
(100 %)
0 diff
(100 %id)
BF696653 brain, primitive neuroectoderm .a 77 to 662 1 to 588       588/898
(65 %)
18 diff
(98.0 %id)
AW960192   .a 79 to 601 1 to 523       523/594
(88 %)
11 diff
(98.2 %id)
CX865674 embryonic stem .a 86 to 801 15 to 730       716/730
(98 %)
5 diff
(99.4 %id)
AW239243 lung, cell line .a 114 to 578 1 to 465       465/465
(100 %)
0 diff
(100 %id)
CX865599 embryonic stem .a 1328 to 1840 545 to 33   AAA   513/514
(99 %)
7 diff
(98.7 %id)
DB446773 testis .b 1 to 438 1 to 438   tiling clone,   438/438
(100 %)
1 diff
(99.8 %id)
NM_145697.2   .b 34 to 2022 1 to 1989 exact RefSeq,   1989/1989
(100 %)
0 diff
(100 %id)
DB453134 testis .b 36 to 528 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
BG354574   .b 46 to 2015 1 to 1970 exact     1970/1970
(100 %)
1 diff
(100.0 %id)
AK093348 testis .b 55 to 2016 1 to 1962 exact tiling clone, available from FLJ,   1962/1962
(100 %)
0 diff
(100 %id)
AX748068   .b 55 to 2016 1 to 1962 exact     1962/1962
(100 %)
0 diff
(100 %id)
DB032504 testis .b 56 to 605 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
CV813136 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 67 to 867 1 to 802       802/887
(90 %)
11 diff
(98.8 %id)
DB053296 testis .b 74 to 624 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
DA644562   .b 94 to 629 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA497093 brain .b 95 to 674 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DB491329 hypothalamus .b 101 to 523 1 to 423       423/423
(100 %)
1 diff
(99.8 %id)
DA667083   .b 102 to 648 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA737855   .b 110 to 971 2 to 869   capped   868/876
(99 %)
10 diff
(98.9 %id)
BQ231714 melanotic melanoma, skin .b 116 to 937 1 to 823       823/843
(97 %)
4 diff
(99.6 %id)
AB050577   .b 119 to 1830 1 to 1712 S229L     1712/1712
(100 %)
2 diff
(99.9 %id)
AA205785   .b 119 to 656 1 to 537       537/537
(100 %)
2 diff
(99.7 %id)
BE882537 leiomyosarcoma, uterus .b 131 to 768 1 to 638       638/946
(67 %)
1 diff
(99.9 %id)
BM453319 melanotic melanoma, skin .b 136 to 937 1 to 805       805/885
(90 %)
14 diff
(98.5 %id)
BE897568 melanotic melanoma, skin .b 144 to 942 1 to 803       801/875
(91 %)
22 diff
(97.5 %id)
DA889039   .b 147 to 707 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
CN483566 eye .b 152 to 802 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
AA305174 colon .b 157 to 558 1 to 402       402/402
(100 %)
2 diff
(99.6 %id)
DB120474 thymus .b 162 to 730 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BX425785 neuroblastoma .b 167 to 1002 1 to 840       840/840
(100 %)
26 diff
(97.0 %id)
BU598632 mixed (pool of 40 RNAs) .b 278 to 943 1 to 665       665/849
(78 %)
15 diff
(98.3 %id)
CV027503 mixed .b 334 to 939 1 to 605       605/605
(100 %)
0 diff
(100 %id)
TI_1948130826   .b 334 to 939 125 to 731       607/1079
(56 %)
21 diff
(98.1 %id)
TI_1948130827   .b 334 to 1171 131 to 970       840/1254
(66 %)
20 diff
(98.5 %id)
TI_1948131152   .b 334 to 1002 127 to 793       669/1079
(62 %)
19 diff
(98.3 %id)
TI_1948131153   .b 334 to 1277 131 to 1078       948/1281
(74 %)
39 diff
(97.0 %id)
TI_1948131481   .b 334 to 1008 125 to 798       674/1111
(60 %)
14 diff
(98.8 %id)
TI_1948131482   .b 334 to 1260 126 to 1060       935/1289
(72 %)
31 diff
(97.6 %id)
TI_1948131806   .b 334 to 942 123 to 733       611/1115
(54 %)
17 diff
(98.5 %id)
TI_1948131807   .b 334 to 1140 126 to 933       808/1256
(64 %)
13 diff
(99.0 %id)
BG504623 embryonal carcinoma, testis .b 379 to 1060 1 to 686       684/699
(97 %)
16 diff
(97.8 %id)
AI809516 pooled .b 568 to 1096 529 to 1       529/529
(100 %)
2 diff
(99.7 %id)
CN366171 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 586 to 1162 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
AI018298 pooled .b 628 to 1099 472 to 1       472/472
(100 %)
1 diff
(99.8 %id)
BG025438 lymph, lymphoma, cell line .b 638 to 1444 1 to 803       801/830
(96 %)
34 diff
(96.0 %id)
BF570968 melanotic melanoma, high MDR, skin .b 652 to 1281 1 to 633       633/1407
(44 %)
42 diff
(97.1 %id)
BE777530 bone marrow, from chronic myelogenous leukemia .b 655 to 1058 1 to 405       405/856
(47 %)
6 diff
(99.3 %id)
BG528344 lung, mucoepidermoid carcinoma .b 673 to 1336 1 to 671       669/852
(78 %)
18 diff
(97.9 %id)
BF690758 melanotic melanoma, high MDR, skin .b 704 to 1384 1 to 674   AAA   674/863
(78 %)
12 diff
(98.7 %id)
DB093987 testis .b 724 to 1281 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BG778500 adenocarcinoma, Prostate .b 733 to 1481 1 to 750       750/750
(100 %)
5 diff
(99.4 %id)
BU561224 testis .b 748 to 1456 1 to 713       713/726
(98 %)
8 diff
(98.9 %id)
TI_1948131155   .b 761 to 1725 1081 to 128       956/1193
(80 %)
33 diff
(97.3 %id)
BC021171 Lung, mucoepidermoid carcinoma .b 765 to 2015 1 to 1251   available from MGC, AAA   1251/1251
(100 %)
2 diff
(99.9 %id)
AA911732 pooled germ cell tumors .b 782 to 1095 314 to 1       314/314
(100 %)
1 diff
(99.7 %id)
BE958093 brain, primitive neuroectoderm .b 784 to 1336 1 to 550       550/859
(64 %)
15 diff
(98.3 %id)
BU569105 testis .b 806 to 1544 1 to 744       744/744
(100 %)
12 diff
(98.4 %id)
AB050578   .b 815 to 2016 1 to 1202   AAA   1202/1202
(100 %)
1 diff
(100.0 %id)
FN095328 breast carcinoma .b 840 to 939 1 to 99       99/99
(100 %)
4 diff
(96.0 %id)
TI_1948131809   .b 842 to 1733 1009 to 122       888/1159
(76 %)
16 diff
(98.7 %id)
TI_1948130829   .b 857 to 1733 991 to 118       874/1167
(74 %)
13 diff
(98.9 %id)
BE613701 leiomyosarcoma, uterus .b 867 to 1462 1 to 596   AAA   596/866
(68 %)
7 diff
(99.2 %id)
TI_1948131154   .b 878 to 1725 976 to 122       853/1281
(66 %)
17 diff
(98.7 %id)
BF033775 adenocarcinoma, ovary .b 924 to 1533 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BM761282 myeloma .b 925 to 1416 1 to 492       492/492
(100 %)
1 diff
(99.8 %id)
AA330249   .b 938 to 1195 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
AW955671   .b 939 to 1577 1 to 639       639/642
(99 %)
12 diff
(98.2 %id)
TI_1948130828   .b 951 to 1733 895 to 104       792/1287
(61 %)
14 diff
(99.0 %id)
CB132651 Liver .b 957 to 1454 54 to 551       498/551
(90 %)
6 diff
(99.0 %id)
BG497357 lung, mucoepidermoid carcinoma .b 1001 to 1649 1 to 651       651/653
(99 %)
6 diff
(99.1 %id)
BF697384 brain, primitive neuroectoderm .b 1021 to 1687 1 to 666       666/902
(73 %)
24 diff
(97.4 %id)
TI_1948131808   .b 1025 to 1733 861 to 142       720/1388
(51 %)
16 diff
(98.9 %id)
BG119621 adenocarcinoma, cell line, Liver .b 1100 to 1941 1 to 835       835/1105
(75 %)
38 diff
(96.6 %id)
DN919104   .b 1132 to 1702 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
BX283986 adenocarcinoma, Prostate .b 1168 to 1554 1 to 387       387/387
(100 %)
0 diff
(100 %id)
BG777666 adenocarcinoma, Prostate .b 1168 to 1999 1 to 833       833/836
(99 %)
20 diff
(97.7 %id)
BF541021 hypernephroma, Kidney .b 1169 to 1906 1 to 733       733/753
(97 %)
25 diff
(96.7 %id)
BG118875 adenocarcinoma, cell line, Liver .b 1192 to 1975 1 to 780       780/782
(99 %)
18 diff
(97.7 %id)
AA421409   .b 1199 to 1620 1 to 422       422/422
(100 %)
5 diff
(98.9 %id)
Z21210   .b 1261 to 1492 233 to 1       233/233
(100 %)
1 diff
(99.6 %id)
BU570878 testis .b 1268 to 1856 1 to 596       596/821
(72 %)
28 diff
(96.6 %id)
BX435976 T cells (Jurkat cell line) .b 1269 to 2012 750 to 5       746/905
(82 %)
19 diff
(98.0 %id)
BF093674 uterus .b 1301 to 1723 1 to 425       425/425
(100 %)
14 diff
(96.8 %id)
BU622548 cell lines, Chondrosarcoma .b 1308 to 2018 729 to 19   AAA   711/711
(100 %)
0 diff
(100 %id)
CB162966 Liver .b 1314 to 1881 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
CA428550 cell lines, Chondrosarcoma .b 1346 to 2016 689 to 19   AAA   671/671
(100 %)
0 diff
(100 %id)
BY994427   .b 1377 to 2018 25 to 666   AAA   642/666
(96 %)
6 diff
(99.1 %id)
BE966263 leiomyosarcoma, uterus .b 1458 to 2016 574 to 16   AAA   559/791
(70 %)
15 diff
(98.2 %id)
DN919105   .b 1459 to 1917 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
BF209811 bone marrow, from chronic myelogenous leukemia .b 1477 to 2006 1 to 522       522/742
(70 %)
35 diff
(95.3 %id)
DB370476   .b 1485 to 2016 533 to 1       533/535
(99 %)
8 diff
(98.6 %id)
DB524604 testis .b 1504 to 2019 1 to 516     Submitted on the opposite strand 516/516
(100 %)
0 diff
(100 %id)
DB523476 testis .b 1525 to 2019 1 to 495     Submitted on the opposite strand 495/495
(100 %)
1 diff
(99.8 %id)
DB540710 hippocampus .b 1532 to 2019 1 to 488     Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
AI015982 Kidney .b 1536 to 2016 495 to 15   AAA   481/481
(100 %)
0 diff
(100 %id)
BU532142 mixed (pool of 40 RNAs) .b 1541 to 2012 1 to 472       472/478
(98 %)
3 diff
(99.4 %id)
AA707645   .b 1544 to 2018 478 to 4       475/478
(99 %)
0 diff
(100 %id)
DB523283 testis .b 1545 to 2018 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
DB519001 testis .b 1546 to 2022 1 to 477   tiling clone, Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
AW662200 2 pooled high-grade transitional celltumors, genitourinary tract .b 1555 to 2016 462 to 1       462/462
(100 %)
0 diff
(100 %id)
DB518613 testis .b 1557 to 2019 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
DB521350 testis .b 1557 to 2019 1 to 463     Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
DB528592 hippocampus .b 1559 to 2019 1 to 460     Submitted on the opposite strand 460/460
(100 %)
2 diff
(99.6 %id)
AW001937 thymus, pooled .b 1559 to 2016 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AW027095 thymus, pooled .b 1560 to 2019 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
DB511538 testis .b 1564 to 2019 1 to 452     Submitted on the opposite strand 452/452
(100 %)
10 diff
(97.8 %id)
DB512129 testis .b 1575 to 2018 1 to 444     Submitted on the opposite strand 444/444
(100 %)
2 diff
(99.6 %id)
AA774231 lung, lung carcinoma .b 1576 to 2016 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
DB544860 hippocampus .b 1579 to 2019 1 to 441     Submitted on the opposite strand 441/441
(100 %)
3 diff
(99.4 %id)
AI081570 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1579 to 2016 448 to 11   AAA   438/438
(100 %)
0 diff
(100 %id)
DB511879 testis .b 1582 to 2018 1 to 438     Submitted on the opposite strand 438/439
(99 %)
6 diff
(98.7 %id)
DB561801 hypothalamus .b 1591 to 2017 1 to 428     Submitted on the opposite strand 428/431
(99 %)
10 diff
(97.7 %id)
AA810133 germinal center B cell .b 1592 to 2019 438 to 12   AAA   427/431
(99 %)
2 diff
(99.6 %id)
AI623723 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1593 to 2016 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
AW130102 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1593 to 2016 424 to 1       424/424
(100 %)
0 diff
(100 %id)
DB506765 testis .b 1600 to 2018 1 to 437     Submitted on the opposite strand 437/441
(99 %)
27 diff
(93.9 %id)
BG218564   .b 1606 to 2017 16 to 426   AAA   411/426
(96 %)
10 diff
(97.7 %id)
DB507875 testis .b 1608 to 2022 1 to 415     Submitted on the opposite strand 415/415
(100 %)
2 diff
(99.6 %id)
DB337148 testis .b 1638 to 2016 379 to 1       379/379
(100 %)
1 diff
(99.8 %id)
AA629353   .b 1654 to 2018 368 to 4       365/368
(99 %)
0 diff
(100 %id)
AI038782   .b 1661 to 2022 373 to 12   AAA   362/362
(100 %)
0 diff
(100 %id)
FN058745 breast carcinoma .b 1665 to 1735 1 to 71       71/72
(98 %)
3 diff
(95.9 %id)
CN366170 embryonic stem cells, DMSO-treated H9 cellline .b 1666 to 2019 1 to 354   AAA   354/354
(100 %)
0 diff
(100 %id)
AI208694   .b 1667 to 2017 354 to 4       351/354
(99 %)
0 diff
(100 %id)
AW197999 adenocarcinoma, Pancreas .b 1671 to 2019 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AA421171   .b 1688 to 2018 335 to 4       332/335
(99 %)
0 diff
(100 %id)
AA812475   .b 1701 to 2017 320 to 4       317/320
(99 %)
0 diff
(100 %id)
AW295098   .b 1701 to 1929 246 to 18   AAA   229/229
(100 %)
11 diff
(95.2 %id)
H89015 cochlea, ear .b 1704 to 2011 1 to 315       315/324
(97 %)
10 diff
(97.0 %id)
AA383718 thymus .b 1710 to 2019 311 to 1       311/311
(100 %)
1 diff
(99.7 %id)
DW462263 Liver .b 1742 to 1843 17 to 118       102/118
(86 %)
6 diff
(95.0 %id)
AA357223   .b 1748 to 2019 272 to 1       272/274
(99 %)
0 diff
(100 %id)
EC513748 Prostate .b 1814 to 1906 7 to 98       92/102
(90 %)
5 diff
(95.1 %id)
AA764964 germinal center B cell .b 1864 to 2020 165 to 9       157/165
(95 %)
0 diff
(100 %id)
GD138409   .b 1932 to 2020 1 to 89       89/103
(86 %)
2 diff
(98.1 %id)
EH334860   .b 1933 to 1995 1 to 63       63/63
(100 %)
0 diff
(100 %id)
DA731056   .c 1 to 791 2 to 800   tiling clone, capped   799/844
(94 %)
13 diff
(98.5 %id)
CR605406 Neuroblastoma Cot 25-normalized .c 10 to 1699 1 to 1690 exact tiling clone,   1690/1690
(100 %)
0 diff
(100 %id)
BX394347 Neuroblastoma Cot 25-normalized .c 24 to 887 14 to 876   fully sequenced,   863/876
(98 %)
7 diff
(99.3 %id)
BX394346 Neuroblastoma Cot 25-normalized .c 826 to 1699 874 to 1   fully sequenced,   874/874
(100 %)
8 diff
(99.1 %id)
DB363116   .c 1170 to 1729 553 to 1   tiling clone,   553/572
(96 %)
16 diff
(97.3 %id)
CR619637 fetal liver .d 1 to 1630 4 to 1633 exact tiling clone,   1633/1633
(100 %)
0 diff
(100 %id)
AL531815 brain, fetal liver, Liver, neuroblastoma cells .d 1 to 896 4 to 900   fully sequenced,   900/900
(100 %)
4 diff
(99.6 %id)
AL531814 brain, fetal liver, Liver, neuroblastoma cells .d 836 to 1630 795 to 1   fully sequenced,   795/795
(100 %)
4 diff
(99.5 %id)
BU521688 leiomyosarcoma, uterus .e 1 to 876 1 to 877 N195X Q213X tiling clone,   877/888
(98 %)
9 diff
(99.0 %id)
BI560690 testis .f 1 to 707 1 to 701   tiling clone,   701/701
(100 %)
15 diff
(97.9 %id)
TI_44349680   .f 6 to 707 84 to 779       696/779
(89 %)
15 diff
(98.1 %id)
DB455926 testis .f 25 to 508 1 to 484   tiling clone,   484/484
(100 %)
0 diff
(100 %id)
BX443441 T cells (Jurkat cell line) .f 98 to 1135 1 to 1032   tiling clone,   1032/1032
(100 %)
12 diff
(98.9 %id)
BI459917 testis .g 1 to 671 1 to 670   tiling clone,   670/670
(100 %)
7 diff
(99.0 %id)
CD244365 testis .g 19 to 799 18 to 803 A107G D108* tiling clone,   786/884
(88 %)
16 diff
(98.2 %id)
TI_44171756   .g 29 to 698 76 to 745       670/745
(89 %)
6 diff
(99.2 %id)
BI552130 brain, hippocampus .g 30 to 698 1 to 669   tiling clone,   669/669
(100 %)
4 diff
(99.5 %id)
DB459114 testis .g 37 to 515 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
DB047322 testis .g 40 to 602 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DB446977 testis .g 42 to 481 1 to 440       440/440
(100 %)
0 diff
(100 %id)
DA747625   .g 43 to 597 2 to 557   capped   556/556
(100 %)
4 diff
(99.3 %id)
DB048651 testis .h 1 to 566 2 to 568 V56A tiling clone, capped   567/567
(100 %)
3 diff
(99.5 %id)
DA617469   .i 1 to 582 2 to 585   tiling clone, capped   584/584
(100 %)
3 diff
(99.5 %id)
BU660046 blood .i 59 to 404 13 to 358   tiling clone,   346/358
(96 %)
8 diff
(97.8 %id)
CN273743 embryonic stem cells, DMSO-treated H9 cellline .i 554 to 829 1 to 277   tiling clone,   277/277
(100 %)
2 diff
(99.3 %id)
AI868551 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j 1 to 351 351 to 1 exact tiling clone,   351/351
(100 %)
1 diff
(99.8 %id)
DB442929 testis .k 1 to 417 1 to 413       413/413
(100 %)
5 diff
(98.8 %id)
DB453534 testis .k 1 to 502 1 to 502   tiling clone,   502/502
(100 %)
1 diff
(99.9 %id)
BI545465 brain, hippocampus .k 40 to 714 1 to 676 M79I E80G G81R F82L P84T ... tiling clone,   676/676
(100 %)
6 diff
(99.2 %id)
DB471956 hippocampus .k 45 to 542 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
TI_44165543   .k 46 to 714 121 to 790 M79I E80G G81R F82L P84T ...     670/790
(84 %)
7 diff
(99.2 %id)
BI460060 testis .k 63 to 667 1 to 603   tiling clone,   603/603
(100 %)
9 diff
(98.6 %id)
BI464541 testis .k 63 to 655 1 to 592       592/592
(100 %)
7 diff
(98.9 %id)
DB441839 testis .k 68 to 502 1 to 437       437/437
(100 %)
3 diff
(99.4 %id)
DB457791 testis .k 68 to 578 1 to 511       511/511
(100 %)
2 diff
(99.7 %id)
DB457976 testis .k 68 to 556 1 to 488       488/488
(100 %)
3 diff
(99.4 %id)
BX505135   .l 1 to 631 7 to 633 N34D tiling clone,   633/634
(99 %)
10 diff
(98.5 %id)
DR158878 human embryonic stem cells differentiated toan early endodermal cell type .l 17 to 774 11 to 768 exact tiling clone,   758/758
(100 %)
0 diff
(100 %id)
CN366168 embryonic stem cells, DMSO-treated H9 cellline .l 115 to 648 1 to 534 exact     534/534
(100 %)
0 diff
(100 %id)
R92525 liver and spleen .l 217 to 576 57 to 425 I59N R60S L61T E62G H63T ...     369/425
(86 %)
17 diff
(96.0 %id)
AA173507   .m 1 to 330 1 to 331   tiling clone,   331/332
(99 %)
2 diff
(99.4 %id)
AW976357   .m 335 to 1023 684 to 1   tiling clone, Submitted on the opposite strand 684/686
(99 %)
15 diff
(97.9 %id)
AA383719 thymus .m 349 to 626 1 to 278   tiling clone,   278/278
(100 %)
0 diff
(100 %id)
AA705188 liver and spleen .m 585 to 1024 440 to 1       440/440
(100 %)
1 diff
(99.8 %id)
AA742948 germinal center B cell .m 620 to 1034 415 to 1   tiling clone,   415/415
(100 %)
0 diff
(100 %id)
AA173417   .m 655 to 1029 376 to 1       376/376
(100 %)
1 diff
(99.8 %id)
AW665335 pooled .m 720 to 1025 306 to 1       306/306
(100 %)
1 diff
(99.7 %id)
BE086829 breast .m 771 to 1018 260 to 13     Submitted on the opposite strand 248/268
(92 %)
0 diff
(100 %id)
AW591940 pooled .m 789 to 1038 250 to 1   tiling clone,   250/250
(100 %)
0 diff
(100 %id)
DB132278 thymus .n 1 to 523 2 to 524 A27V tiling clone, to resequence, capped   523/523
(100 %)
1 diff
(99.9 %id)
CN277031 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 93 to 742 1 to 651 exact tiling clone,   651/651
(100 %)
2 diff
(99.7 %id)
DB344710 thymus .n 1448 to 2012 565 to 1   tiling clone, to resequence,   565/565
(100 %)
0 diff
(100 %id)
DB004234 breast, tumor tissue .o 1 to 580 2 to 581 exact tiling clone, to resequence, capped   580/580
(100 %)
0 diff
(100 %id)
DB335248 breast, tumor tissue .o 1243 to 1799 557 to 1   tiling clone, to resequence,   557/557
(100 %)
1 diff
(99.9 %id)
CN274335 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p-u 1 to 741 1 to 740 F23C Q68E tiling clone,   740/740
(100 %)
5 diff
(99.4 %id)
BU561441 testis .q 1 to 708 1 to 712 exact tiling clone,   711/791
(89 %)
13 diff
(98.4 %id)
BG181574   .r 1 to 483 1 to 484 P3T R5X L6A E7* tiling clone, AAA   484/484
(100 %)
6 diff
(98.8 %id)
BG189987   .r 8 to 481 8 to 482   tiling clone,   475/773
(61 %)
7 diff
(99.1 %id)
AA357224   .s-u 1 to 213 1 to 213 exact tiling clone,   213/213
(100 %)
2 diff
(99.1 %id)
AL043450 testis Gene NUF2, variant not shown         This clone was ignored    
AL043451 testis Gene NUF2, variant not shown         This clone was ignored    
BQ213421 embryonal carcinoma, cell line, testis Gene NUF2, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
DB087499 testis Gene NUF2, variant not shown       capped This clone was ignored    
DB341203 testis Gene NUF2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r, .s-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI